Loading...
•
Sep 30, 2025
CryoPort Q3 2025 Earnings Report
CryoPort reported solid Q3 2025 revenue growth with expanded gross margins and continued support for commercial cell & gene therapies.
Key Takeaways
CryoPort delivered 15% year-over-year revenue growth in Q3 2025, driven by both Life Sciences Services and Life Sciences Products, with expansion in commercial cell & gene therapy support and a solid gross margin, while narrowing adjusted EBITDA losses. :contentReference[oaicite:0]{index=0}
Total Q3 2025 revenue increased 15% year-over-year to 44233000. :contentReference[oaicite:1]{index=1}
Commercial Cell & Gene Therapy revenue grew 36% YoY to 8300000. :contentReference[oaicite:2]{index=2}
Life Sciences Services revenue grew 16% YoY to 24258000. :contentReference[oaicite:3]{index=3}
Gross margin improved to 48.2% and adjusted EBITDA loss narrowed. :contentReference[oaicite:4]{index=4}
Revenue by Segment
Forward Guidance
CryoPort raised full-year 2025 revenue guidance to a range of $170.0M to $174.0M. :contentReference[oaicite:9]{index=9}
Positive Outlook
- Revenue guidance raised to $170M–$174M. :contentReference[oaicite:10]{index=10}
- Commercial cell & gene therapy support growing strongly. :contentReference[oaicite:11]{index=11}
- Gross margin expansion. :contentReference[oaicite:12]{index=12}
- Continued operational momentum and strategic expansions mentioned. :contentReference[oaicite:13]{index=13}
- Adjusted EBITDA losses narrowing. :contentReference[oaicite:14]{index=14}
Challenges Ahead
- Adjusted EBITDA remains negative. :contentReference[oaicite:15]{index=15}
- Net loss persists in the quarter. :contentReference[oaicite:16]{index=16}
- Macro risks cited in outlook. :contentReference[oaicite:17]{index=17}
- Potential impacts from regulatory uncertainties. :contentReference[oaicite:18]{index=18}
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...